Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS · Delayed Price · Currency is USD
0.0004
-0.0107 (-96.40%)
May 14, 2026, 4:00 PM EST
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $497 as of May 19, 2026. Its market cap has decreased by -99.98% in one year.
Market Cap
497.00
Enterprise Value
-1.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 497.00, a decrease of -100.00%. That is a compound annual growth rate of -87.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 497.00 | -96.40% |
| Dec 31, 2025 | 13.79K | -99.55% |
| Dec 31, 2024 | 3.07M | -18.06% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
| Feb 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biora Therapeutics | 885.00 |
| RegeneRx Biopharmaceuticals | 754.00 |
| Alzex Neuropharma | 753.00 |
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |
| Amarantus BioScience Holdings | 630.00 |
| GlobeImmune | 575.00 |
| Mera Pharmaceuticals | 537.00 |